Page last updated: 2024-09-23

hederagenin

Cross-References

ID SourceID
PubMed CID73299
CHEMBL ID486400
CHEBI ID69579
SCHEMBL ID359809
MeSH IDM0085532

Synonyms (52)

Synonym
astrantiagenin e
465-99-6
hederagenol
caulosapogenin
olean-12-en-28-oic acid,23-dihydroxy-
olean-12-en-28-oic acid,23-dihydroxy-, (3.beta.,4.alpha.)-
nsc24954
hederagenin ,
nsc-24954
einecs 207-369-9
nsc 24954
hederagenic acid
(3beta,4alpha)-3,23-dihydroxyolean-12-en-28-oic acid
(3-beta,4-alpha)-3,23-dihydroxyolean-12-en-28-oic acid
olean-12-en-28-oic acid, 3,23-dihydroxy-, (3beta,4alpha)-
olean-12-en-28-oic acid, 3beta,23-dihydroxy-
olean-12-en-28-oic acid, 3,23-dihydroxy-, (3-beta,4-alpha)-
(4as,6ar,6as,6br,8ar,9r,10s,12ar,14bs)-10-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
4-epi-hederagenin
CHEMBL486400
chebi:69579 ,
S3899
AKOS016036289
rqf57j8212 ,
olean-12-en-28-oic acid, 3-beta,23-dihydroxy-
unii-rqf57j8212
hederagenine
(3beta)-3,23-dihydroxyolean-12-en-28-oic acid
hederagenin, (+)-
olean-12-en-28-oic acid, 3,23-dihydroxy-, (3.beta.,4.alpha.)-
olean-12-en-28-oic acid, 3.beta.,23-dihydroxy-
hederagenin [mi]
bdbm50442880
H1645
SCHEMBL359809
Q-100493
mfcd00017385
HY-N0256
CS-5454
AS-68383
(4as,6ar,6as,6br,8ar,9r,10s,12ar,14bs)-10-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylicacid
hederagenin, >=97% (hplc)
Q5697238
(4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid
hederagenin,(s)
3beta,4alpha-3,23-dihydroxyolean-12-en-28-oic acid
CCG-269472
olean-12-en-28-oic acid, 3,23-dihydroxy-, (3b,4a)-
3ss,4a-3,23-dihydroxyolean-12-en-28-oicacid
A872247
DTXSID301029412
olean-12-en-28-oic acid, 3-beta,23-dihydroxy-(6ci,7ci,8ci)

Research Excerpts

Overview

ExcerptReference
"Hederagenin is a triterpenoid saponin from some Chinese herbs with anti-inflammatory and anti-diabetic activities."( Jiang, H; Ma, W; Yang, G; Yang, W; Yi, Q, 2023)
"Hederagenin is a pentacyclic triterpenoid that is widely distributed as the main pharmaceutical ingredient in various medicinal plants. "( Bi, Y; Fang, X; Han, S; Li, H; Lu, X; Xie, W; Yang, D, 2023)
"Hederagenin (Hed) is a pentacyclic triterpenoid saponin extracted from various natural medicinal plants and exhibits numerous biological activities and may offer benefits against bone-related conditions."( Ding, J; Li, Y; Liang, J; Lin, X; Liu, Q; Song, F; Su, Y; Tian, K; Wang, D; Wang, Z; Xu, J; Zhan, Y; Zhao, J, 2020)
"Hederagenin (HDG) is a pentacyclic triterpenoid saponin widely distributed in various plants."( Deng, L; He, Y; Huang, Q; Ma, W; Xiong, G, 2020)
"Hederagenin is a representative precursor for hemolytic saponin in plants."( Choi, YE; Chun, JH; Han, JY; Hwang, HS; Lee, H; Oh, SA; Park, SB, 2018)
"Hederagenin is an effective constituent of many medical plants, such as Clematidis Radix, and has a wide range of applications in anti-tumor, anti-inflammatory, antidepressant, hepatoprotective antibacterial, et al. "( Dai, ZB; Li, WX; Lu, FP; Ma, XL; Wang, D; Zhang, XL, 2018)
"Hederagenin was found to be an essential moiety for the exhibition of antimutagenicity."( Jung, GO; Kim, DW; Lee, KT; Park, HJ; Park, KY; Sohn, IC, 2000)

Actions

ExcerptReference
"Hederagenin (HE) plays a protective role by inhibiting cell proliferation and ameliorating fibrosis. "( He, L; Yang, W, 2022)

Treatment

ExcerptReference
"Treatment with hederagenin (10, 30 and 100μM) resulted in inhibited levels of protein expression of lipopolysaccharide-stimulated iNOS, COX-2, and NF-κB as well as production of NO, PGE2, TNF-α, IL-1β, and IL-6 induced by lipopolysaccharide."( An, WG; Cho, IJ; Chun, W; Jegal, KH; Ju, SA; Jung, JY; Kim, SC; Kim, SH; Kim, YW; Ku, SK; Lee, C; Lee, CW; Park, SM; Son, Y; Zhao, R, 2015)

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
pentacyclic triterpenoid
dihydroxy monocarboxylic acidAny hydroxy monocarboxylic acid carrying at least two hydroxy groups.
sapogeninAny organic polycyclic compound that is the aglycon moiety of a saponin; sapogenins may be steroids or triterpenoids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)IC50 (µMol)40.00000.03201.46494.8000AID1617776
Epidermal growth factor receptorHomo sapiens (human)IC50 (µMol)20.00000.00000.536910.0000AID1617466; AID1617467; AID1617468
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)IC50 (µMol)40.00000.00011.68479.3200AID1617774
Tissue factorHomo sapiens (human)IC50 (µMol)0.00020.00010.734410.0000AID1436859
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)IC50 (µMol)0.89130.10472.71957.0795AID977603
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)Ki0.68000.08002.46889.8000AID977604
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)IC50 (µMol)3.80190.05002.37979.7000AID977600
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)Ki2.11000.04401.36305.0000AID977601
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (159)

Processvia Protein(s)Taxonomy
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cell surface receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell population proliferationEpidermal growth factor receptorHomo sapiens (human)
MAPK cascadeEpidermal growth factor receptorHomo sapiens (human)
ossificationEpidermal growth factor receptorHomo sapiens (human)
embryonic placenta developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein phosphorylationEpidermal growth factor receptorHomo sapiens (human)
hair follicle developmentEpidermal growth factor receptorHomo sapiens (human)
translationEpidermal growth factor receptorHomo sapiens (human)
signal transductionEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
activation of phospholipase C activityEpidermal growth factor receptorHomo sapiens (human)
salivary gland morphogenesisEpidermal growth factor receptorHomo sapiens (human)
midgut developmentEpidermal growth factor receptorHomo sapiens (human)
learning or memoryEpidermal growth factor receptorHomo sapiens (human)
circadian rhythmEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell population proliferationEpidermal growth factor receptorHomo sapiens (human)
diterpenoid metabolic processEpidermal growth factor receptorHomo sapiens (human)
peptidyl-tyrosine phosphorylationEpidermal growth factor receptorHomo sapiens (human)
cerebral cortex cell migrationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell growthEpidermal growth factor receptorHomo sapiens (human)
lung developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cell migrationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of superoxide anion generationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationEpidermal growth factor receptorHomo sapiens (human)
response to cobalaminEpidermal growth factor receptorHomo sapiens (human)
response to hydroxyisoflavoneEpidermal growth factor receptorHomo sapiens (human)
cellular response to reactive oxygen speciesEpidermal growth factor receptorHomo sapiens (human)
peptidyl-tyrosine autophosphorylationEpidermal growth factor receptorHomo sapiens (human)
ERBB2-EGFR signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
negative regulation of epidermal growth factor receptor signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
negative regulation of protein catabolic processEpidermal growth factor receptorHomo sapiens (human)
vasodilationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of phosphorylationEpidermal growth factor receptorHomo sapiens (human)
ovulation cycleEpidermal growth factor receptorHomo sapiens (human)
hydrogen peroxide metabolic processEpidermal growth factor receptorHomo sapiens (human)
negative regulation of apoptotic processEpidermal growth factor receptorHomo sapiens (human)
positive regulation of MAP kinase activityEpidermal growth factor receptorHomo sapiens (human)
tongue developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityEpidermal growth factor receptorHomo sapiens (human)
positive regulation of DNA repairEpidermal growth factor receptorHomo sapiens (human)
positive regulation of DNA replicationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of bone resorptionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of DNA-templated transcriptionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of vasoconstrictionEpidermal growth factor receptorHomo sapiens (human)
negative regulation of mitotic cell cycleEpidermal growth factor receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIEpidermal growth factor receptorHomo sapiens (human)
regulation of JNK cascadeEpidermal growth factor receptorHomo sapiens (human)
symbiont entry into host cellEpidermal growth factor receptorHomo sapiens (human)
protein autophosphorylationEpidermal growth factor receptorHomo sapiens (human)
astrocyte activationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of fibroblast proliferationEpidermal growth factor receptorHomo sapiens (human)
digestive tract morphogenesisEpidermal growth factor receptorHomo sapiens (human)
positive regulation of smooth muscle cell proliferationEpidermal growth factor receptorHomo sapiens (human)
neuron projection morphogenesisEpidermal growth factor receptorHomo sapiens (human)
epithelial cell proliferationEpidermal growth factor receptorHomo sapiens (human)
positive regulation of epithelial cell proliferationEpidermal growth factor receptorHomo sapiens (human)
regulation of peptidyl-tyrosine phosphorylationEpidermal growth factor receptorHomo sapiens (human)
protein insertion into membraneEpidermal growth factor receptorHomo sapiens (human)
response to calcium ionEpidermal growth factor receptorHomo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicEpidermal growth factor receptorHomo sapiens (human)
positive regulation of glial cell proliferationEpidermal growth factor receptorHomo sapiens (human)
morphogenesis of an epithelial foldEpidermal growth factor receptorHomo sapiens (human)
eyelid development in camera-type eyeEpidermal growth factor receptorHomo sapiens (human)
response to UV-AEpidermal growth factor receptorHomo sapiens (human)
positive regulation of mucus secretionEpidermal growth factor receptorHomo sapiens (human)
regulation of ERK1 and ERK2 cascadeEpidermal growth factor receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeEpidermal growth factor receptorHomo sapiens (human)
cellular response to amino acid stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to mechanical stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to cadmium ionEpidermal growth factor receptorHomo sapiens (human)
cellular response to epidermal growth factor stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to estradiol stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to xenobiotic stimulusEpidermal growth factor receptorHomo sapiens (human)
cellular response to dexamethasone stimulusEpidermal growth factor receptorHomo sapiens (human)
positive regulation of canonical Wnt signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
liver regenerationEpidermal growth factor receptorHomo sapiens (human)
cell-cell adhesionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein kinase C activityEpidermal growth factor receptorHomo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleEpidermal growth factor receptorHomo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of prolactin secretionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of miRNA transcriptionEpidermal growth factor receptorHomo sapiens (human)
positive regulation of protein localization to plasma membraneEpidermal growth factor receptorHomo sapiens (human)
negative regulation of cardiocyte differentiationEpidermal growth factor receptorHomo sapiens (human)
neurogenesisEpidermal growth factor receptorHomo sapiens (human)
multicellular organism developmentEpidermal growth factor receptorHomo sapiens (human)
positive regulation of kinase activityEpidermal growth factor receptorHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayEpidermal growth factor receptorHomo sapiens (human)
negative regulation of endothelial cell proliferationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte chemotaxis involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte migration involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
humoral immune responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of bone mineralizationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
dendritic cell migrationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
glucose homeostasisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
long-chain fatty acid biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of fat cell differentiationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of insulin secretionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of vascular wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory response to woundingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cytokine production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cellular response to oxidative stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene A4 biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of response to endoplasmic reticulum stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of sprouting angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of leukocyte adhesion to arterial endothelial cellPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxin biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of gene expressionTissue factorHomo sapiens (human)
positive regulation of interleukin-8 productionTissue factorHomo sapiens (human)
positive regulation of endothelial cell proliferationTissue factorHomo sapiens (human)
activation of plasma proteins involved in acute inflammatory responseTissue factorHomo sapiens (human)
activation of blood coagulation via clotting cascadeTissue factorHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processTissue factorHomo sapiens (human)
blood coagulationTissue factorHomo sapiens (human)
positive regulation of platelet-derived growth factor receptor signaling pathwayTissue factorHomo sapiens (human)
protein processingTissue factorHomo sapiens (human)
positive regulation of cell migrationTissue factorHomo sapiens (human)
positive regulation of TOR signalingTissue factorHomo sapiens (human)
positive regulation of angiogenesisTissue factorHomo sapiens (human)
positive regulation of positive chemotaxisTissue factorHomo sapiens (human)
cytokine-mediated signaling pathwayTissue factorHomo sapiens (human)
xenobiotic metabolic processSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
monoatomic ion transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
organic anion transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
bile acid and bile salt transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
heme catabolic processSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
sodium-independent organic anion transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
transmembrane transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
xenobiotic metabolic processSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
monoatomic ion transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
organic anion transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
bile acid and bile salt transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
prostaglandin transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
heme catabolic processSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
sodium-independent organic anion transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
transmembrane transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
thyroid hormone transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (44)

Processvia Protein(s)Taxonomy
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
epidermal growth factor receptor activityEpidermal growth factor receptorHomo sapiens (human)
virus receptor activityEpidermal growth factor receptorHomo sapiens (human)
chromatin bindingEpidermal growth factor receptorHomo sapiens (human)
double-stranded DNA bindingEpidermal growth factor receptorHomo sapiens (human)
MAP kinase kinase kinase activityEpidermal growth factor receptorHomo sapiens (human)
protein tyrosine kinase activityEpidermal growth factor receptorHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activityEpidermal growth factor receptorHomo sapiens (human)
transmembrane signaling receptor activityEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor receptor activityEpidermal growth factor receptorHomo sapiens (human)
integrin bindingEpidermal growth factor receptorHomo sapiens (human)
protein bindingEpidermal growth factor receptorHomo sapiens (human)
calmodulin bindingEpidermal growth factor receptorHomo sapiens (human)
ATP bindingEpidermal growth factor receptorHomo sapiens (human)
enzyme bindingEpidermal growth factor receptorHomo sapiens (human)
kinase bindingEpidermal growth factor receptorHomo sapiens (human)
protein kinase bindingEpidermal growth factor receptorHomo sapiens (human)
protein phosphatase bindingEpidermal growth factor receptorHomo sapiens (human)
protein tyrosine kinase activator activityEpidermal growth factor receptorHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activator activityEpidermal growth factor receptorHomo sapiens (human)
ubiquitin protein ligase bindingEpidermal growth factor receptorHomo sapiens (human)
identical protein bindingEpidermal growth factor receptorHomo sapiens (human)
cadherin bindingEpidermal growth factor receptorHomo sapiens (human)
actin filament bindingEpidermal growth factor receptorHomo sapiens (human)
ATPase bindingEpidermal growth factor receptorHomo sapiens (human)
epidermal growth factor bindingEpidermal growth factor receptorHomo sapiens (human)
arachidonate 5-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 12(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
iron ion bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
protein bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
hydrolase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
serine-type endopeptidase activityTissue factorHomo sapiens (human)
protease bindingTissue factorHomo sapiens (human)
protein bindingTissue factorHomo sapiens (human)
phospholipid bindingTissue factorHomo sapiens (human)
cytokine receptor activityTissue factorHomo sapiens (human)
serine-type endopeptidase inhibitor activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
bile acid transmembrane transporter activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
bile acid transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
thyroid hormone transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (40)

Processvia Protein(s)Taxonomy
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endosomeEpidermal growth factor receptorHomo sapiens (human)
plasma membraneEpidermal growth factor receptorHomo sapiens (human)
ruffle membraneEpidermal growth factor receptorHomo sapiens (human)
Golgi membraneEpidermal growth factor receptorHomo sapiens (human)
extracellular spaceEpidermal growth factor receptorHomo sapiens (human)
nucleusEpidermal growth factor receptorHomo sapiens (human)
cytoplasmEpidermal growth factor receptorHomo sapiens (human)
endosomeEpidermal growth factor receptorHomo sapiens (human)
endoplasmic reticulum membraneEpidermal growth factor receptorHomo sapiens (human)
plasma membraneEpidermal growth factor receptorHomo sapiens (human)
focal adhesionEpidermal growth factor receptorHomo sapiens (human)
cell surfaceEpidermal growth factor receptorHomo sapiens (human)
endosome membraneEpidermal growth factor receptorHomo sapiens (human)
membraneEpidermal growth factor receptorHomo sapiens (human)
basolateral plasma membraneEpidermal growth factor receptorHomo sapiens (human)
apical plasma membraneEpidermal growth factor receptorHomo sapiens (human)
cell junctionEpidermal growth factor receptorHomo sapiens (human)
clathrin-coated endocytic vesicle membraneEpidermal growth factor receptorHomo sapiens (human)
early endosome membraneEpidermal growth factor receptorHomo sapiens (human)
nuclear membraneEpidermal growth factor receptorHomo sapiens (human)
membrane raftEpidermal growth factor receptorHomo sapiens (human)
perinuclear region of cytoplasmEpidermal growth factor receptorHomo sapiens (human)
multivesicular body, internal vesicle lumenEpidermal growth factor receptorHomo sapiens (human)
intracellular vesicleEpidermal growth factor receptorHomo sapiens (human)
protein-containing complexEpidermal growth factor receptorHomo sapiens (human)
receptor complexEpidermal growth factor receptorHomo sapiens (human)
Shc-EGFR complexEpidermal growth factor receptorHomo sapiens (human)
basal plasma membraneEpidermal growth factor receptorHomo sapiens (human)
extracellular regionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
extracellular spacePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelope lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nucleoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
cytosolPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear matrixPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear membranePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
secretory granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
perinuclear region of cytoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
ficolin-1-rich granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
extracellular spaceTissue factorHomo sapiens (human)
plasma membraneTissue factorHomo sapiens (human)
external side of plasma membraneTissue factorHomo sapiens (human)
cell surfaceTissue factorHomo sapiens (human)
membraneTissue factorHomo sapiens (human)
collagen-containing extracellular matrixTissue factorHomo sapiens (human)
serine-type peptidase complexTissue factorHomo sapiens (human)
plasma membraneTissue factorHomo sapiens (human)
plasma membraneSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
basal plasma membraneSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
basolateral plasma membraneSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
plasma membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
basal plasma membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
basolateral plasma membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (124)

Assay IDTitleYearJournalArticle
AID977604Ki values for sodium fluorescein (10 uM) uptake in OATP1B3-transfected CHO cells2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1617461Antiproliferative activity against human MDA-MB-231 cells incubated for 72 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID1292212Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay2016European journal of medicinal chemistry, Jun-10, Volume: 115Novel hederagenin-triazolyl derivatives as potential anti-cancer agents.
AID1503260Cytotoxicity against human FADU cells assessed as reduction in cell viability incubated fro 96 hrs by SRB assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
AID977600pIC50 values for sodium fluorescein (10 uM) uptake in OATP1B1-transfected CHO cells2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1617775Inhibition of human recombinant 5-LOX expressed in insect cells assessed residual activity using arachidonic acid at 42 uM as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by ferric ion oxidation-xylenol o2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1503262Cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated fro 96 hrs by SRB assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
AID1335272Cytotoxicity against dog DH82 cells assessed as decrease in cell viability after 48 hrs by MTT assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Highly potent anti-leishmanial derivatives of hederagenin, a triperpenoid from Sapindus saponaria L.
AID1256523Cytotoxicity against human 518A2 cells assessed as cell survival after 96 hrs by sulforhodamine B assay2015European journal of medicinal chemistry, Nov-13, Volume: 105Hederagenin as a triterpene template for the development of new antitumor compounds.
AID1903284Cytotoxicity against human KBV cells assessed as decrease in cell survival rate at 10 uM measured after 72 hrs in presence of paclitaxel by MTT assay2022European journal of medicinal chemistry, Mar-15, Volume: 232Design, synthesis, and tumor drug resistance reversal activity of novel hederagenin derivatives modified by nitrogen-containing heterocycles.
AID623339Induction of apoptosis in human M14 cells assessed as activation of caspase-3 at 50 uM after 8 to 24 hrs by Western blot analysis2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Triterpenoid constituents from the roots of Paeonia rockii ssp. rockii.
AID1503734Antiproliferative activity against human KB cells after 72 hrs by MTT assay2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID1543904Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by SRB assay2019European journal of medicinal chemistry, Apr-15, Volume: 168Hederagenin amide derivatives as potential antiproliferative agents.
AID1292209Cytotoxicity against human A2780 cells after 96 hrs by SRB assay2016European journal of medicinal chemistry, Jun-10, Volume: 115Novel hederagenin-triazolyl derivatives as potential anti-cancer agents.
AID393219Cytotoxicity against human A549 cells after 48 hrs by resazurin reduction test2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins.
AID1442271Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay2017European journal of medicinal chemistry, Mar-31, Volume: 129The derivatives of Pulsatilla saponin A, a bioactive compound from Pulsatilla chinensis: Their synthesis, cytotoxicity, haemolytic toxicity and mechanism of action.
AID1617774Inhibition of human recombinant 5-LOX expressed in insect cells assessed as decrease in production of 5-HPETE and 5-HETE using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by ferric io2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1617462Antiproliferative activity against human KB cells incubated for 72 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID1493998Cytotoxicity against human KBVIN cells after 72 hrs by sulforhodamine B assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Cytotoxicity, Hemolytic Toxicity, and Mechanism of Action of Pulsatilla Saponin D and Its Synthetic Derivatives.
AID1442275Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by MTT assay2017European journal of medicinal chemistry, Mar-31, Volume: 129The derivatives of Pulsatilla saponin A, a bioactive compound from Pulsatilla chinensis: Their synthesis, cytotoxicity, haemolytic toxicity and mechanism of action.
AID1503748Cell cycle arrest in human MKN45 cells assessed as accumulation at G2/M-phase at 10 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 19%)2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID1503267Antileishmanial activity against Leishmania infantum MHOM/BR/70/BH46 intracellular amastigotes infected in canine DH82 cells assessed as as inhibition of cell growth at 1000 uM incubated for 48 hrs by ELISA method2017European journal of medicinal chemistry, Nov-10, Volume: 140Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
AID1335274Cytotoxicity against human HepG2 cells assessed as decrease in cell viability after 48 hrs by MTT assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Highly potent anti-leishmanial derivatives of hederagenin, a triperpenoid from Sapindus saponaria L.
AID623342Induction of apoptosis in human M14 cells assessed as increase in hypodiploid cells up to 25 uM after 24 hrs using propidium iodide staining by flow cytometry2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Triterpenoid constituents from the roots of Paeonia rockii ssp. rockii.
AID1503746Cell cycle arrest in human MKN45 cells assessed as accumulation at G1-phase at 10 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 67%)2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID1503743Cell cycle arrest in human MKN45 cells assessed as accumulation at S-phase at 10 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 15%)2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID1503737Antiproliferative activity against human A549 cells after 72 hrs by MTT assay2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID393220Cytotoxicity against human DLD1 cells after 48 hrs by resazurin reduction test2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins.
AID1503275Cytotoxicity in African green monkey BGM cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
AID1503268Antileishmanial activity against Leishmania infantum MHOM/BR/70/BH46 intracellular amastigotes infected in canine DH82 cells assessed as as inhibition of cell growth incubated for 48 hrs by ELISA method2017European journal of medicinal chemistry, Nov-10, Volume: 140Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
AID1494000Cytotoxicity against human MCF7 cells after 72 hrs by sulforhodamine B assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Cytotoxicity, Hemolytic Toxicity, and Mechanism of Action of Pulsatilla Saponin D and Its Synthetic Derivatives.
AID393223Cell membrane permeabilization in human DLD1 cells assessed as drug level causing decrease in calcein fluorescence2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins.
AID1256525Cytotoxicity against human HT-29 cells assessed as cell survival after 96 hrs by sulforhodamine B assay2015European journal of medicinal chemistry, Nov-13, Volume: 105Hederagenin as a triterpene template for the development of new antitumor compounds.
AID772918Cytotoxicity against human HepG2 cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
Bioactive oleanane-type saponins from the rhizomes of Anemone taipaiensis.
AID1503739Antiproliferative activity against human BGC823 cells after 72 hrs by MTT assay2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID772915Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
Bioactive oleanane-type saponins from the rhizomes of Anemone taipaiensis.
AID627012Inhibition of NF-kappaB-induced iNOS mRNA expression in TNF-alpha-stimulated human HepG2 cells at 0.1 to 10 uM after 1 hr by RT-PCR analysis2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Anti-inflammatory triterpenoid saponins from the stem bark of Kalopanax pictus.
AID1503270Selectivity index, ratio of CC50 for dog DH82 cells to IC50 for antileishmanial activity against Leishmania infantum MHOM/BR/70/BH46 intracellular amastigotes infected in canine DH82 cells2017European journal of medicinal chemistry, Nov-10, Volume: 140Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
AID1503742Cell cycle arrest in human MKN45 cells assessed as accumulation at G1-phase at 10 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 67%)2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID1292214Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay2016European journal of medicinal chemistry, Jun-10, Volume: 115Novel hederagenin-triazolyl derivatives as potential anti-cancer agents.
AID1617467Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M double mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo k2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID1503745Cell cycle arrest in human MKN45 cells assessed as apoptotic cell accumulation at 10 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 1.51%)2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID1256528Cytotoxicity against human 8505C cells assessed as cell survival after 96 hrs by sulforhodamine B assay2015European journal of medicinal chemistry, Nov-13, Volume: 105Hederagenin as a triterpene template for the development of new antitumor compounds.
AID1503278Selectivity index, ratio of CC50 for human HepG2 cells to IC50 for antileishmanial activity against Leishmania infantum MHOM/BR/70/BH46 intracellular amastigotes infected in canine DH82 cells2017European journal of medicinal chemistry, Nov-10, Volume: 140Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
AID1335269Selectivity index, ratio of LD50 for dog DH82 cells to IC50 for Leishmania infantum MHOM/BR/70/BH46 promastigotes infected in dog DH82 cells2016European journal of medicinal chemistry, Nov-29, Volume: 124Highly potent anti-leishmanial derivatives of hederagenin, a triperpenoid from Sapindus saponaria L.
AID1543901Cytotoxicity against human FADU cells assessed as reduction in cell viability after 96 hrs by SRB assay2019European journal of medicinal chemistry, Apr-15, Volume: 168Hederagenin amide derivatives as potential antiproliferative agents.
AID1436859Inhibition of LPS-induced tissue factor procoagulant activity in human THP1 cells preincubated for 1 hr followed by LPS addition measured after 5 hrs using factor 10a chromogenic substrate in presence of prothrombin complex2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Microbial hydroxylation and glycosylation of pentacyclic triterpenes as inhibitors on tissue factor procoagulant activity.
AID1442277Cytotoxicity against human KBVIN cells assessed as reduction in cell viability after 48 hrs by MTT assay2017European journal of medicinal chemistry, Mar-31, Volume: 129The derivatives of Pulsatilla saponin A, a bioactive compound from Pulsatilla chinensis: Their synthesis, cytotoxicity, haemolytic toxicity and mechanism of action.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID623340Induction of apoptosis in human M14 cells assessed as activation of caspase-3 at 50 uM after 24 hrs by Western blot analysis presence of polycaspase inhibitor z-VAD-fmk2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Triterpenoid constituents from the roots of Paeonia rockii ssp. rockii.
AID1530706Reversal of P-gp-mediated drug resistance in human KBV cells assessed as potentiation of paclitaxel-induced cytotoxicity by measuring cell survival at 5 uM after 72 hrs by MTT assay (Rvb = 98 +/- 19%)2019European journal of medicinal chemistry, Jan-01, Volume: 161Synthesis and biological evaluation of novel H6 analogues as drug resistance reversal agents.
AID623338Cytotoxicity against human M14 cells after 48 hrs by MTT assay2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Triterpenoid constituents from the roots of Paeonia rockii ssp. rockii.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1617779Inhibition of ovine recombinant COX1 assessed as residual activity at 42 uM using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1335273Selectivity index, ratio of LD50 for African green monkey BGM cells to IC50 for Leishmania infantum MHOM/BR/70/BH46 promastigotes infected in dog DH82 cells2016European journal of medicinal chemistry, Nov-29, Volume: 124Highly potent anti-leishmanial derivatives of hederagenin, a triperpenoid from Sapindus saponaria L.
AID1503738Antiproliferative activity against human MKN45 cells after 72 hrs by MTT assay2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID1543906Cytotoxicity against mouse NIH/3T3 cells assessed as reduction in cell viability after 96 hrs by SRB assay2019European journal of medicinal chemistry, Apr-15, Volume: 168Hederagenin amide derivatives as potential antiproliferative agents.
AID1617460Antiproliferative activity against human A549 cells harbouring wild type EGFR incubated for 72 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID1503263Cytotoxicity against human A375 cells assessed as reduction in cell viability incubated fro 96 hrs by SRB assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
AID1543905Cytotoxicity against human SW1736 cells assessed as reduction in cell viability after 96 hrs by SRB assay2019European journal of medicinal chemistry, Apr-15, Volume: 168Hederagenin amide derivatives as potential antiproliferative agents.
AID1543903Cytotoxicity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by SRB assay2019European journal of medicinal chemistry, Apr-15, Volume: 168Hederagenin amide derivatives as potential antiproliferative agents.
AID1617464Antiproliferative activity against human MCF7 cells incubated for 72 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID1503744Cell cycle arrest in human MKN45 cells assessed as accumulation at G2/M-phase at 10 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 19%)2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID1503264Cytotoxicity against human SW1736 cells assessed as reduction in cell viability incubated fro 96 hrs by SRB assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
AID393222Cell membrane permeabilization in human A549 cells assessed as drug level causing decrease in calcein fluorescence2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins.
AID403015Induction of quinone reductase2005Journal of natural products, Jul, Volume: 68, Issue:7
Limnophilaspiroketone, a highly oxygenated phenolic derivative from Limnophila geoffrayi.
AID1617780Inhibition of human recombinant COX2 expressed in baculovirus infected sf21 cells assessed as decrease in PGE2 formation using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1493994Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Cytotoxicity, Hemolytic Toxicity, and Mechanism of Action of Pulsatilla Saponin D and Its Synthetic Derivatives.
AID1503740Antiproliferative activity against human AGS cells after 72 hrs by MTT assay2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID1617469Antiproliferative activity against human NCI-H1975 cells incubated for 72 hrs by MTS assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID1617466Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID1617470Antiproliferative activity against human NCI-H1975 cells harbouring EGFR L858R/T790M/C797S mutant incubated for 72 hrs by MTS assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID393224Cell membrane permeabilization in human WS1 cells assessed as drug level causing decrease in calcein fluorescence2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins.
AID977601Ki values for sodium fluorescein (10 uM) uptake in OATP1B1-transfected CHO cells2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1617781Inhibition of human recombinant COX2 expressed in baculovirus infected sf21 cells assessed as residual activity at 42 uM using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis r2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID402639Cytotoxicity against human BC cells by colorimetric method2005Journal of natural products, Jul, Volume: 68, Issue:7
Bioactive constituents of the leaves of Phyllanthus polyphyllus var. siamensis.
AID1494001Hemolytic activity against New Zealand rabbit erythrocytes measured after 60 mins2018Journal of natural products, 03-23, Volume: 81, Issue:3
Cytotoxicity, Hemolytic Toxicity, and Mechanism of Action of Pulsatilla Saponin D and Its Synthetic Derivatives.
AID402638Cytotoxicity against human KB cells by colorimetric method2005Journal of natural products, Jul, Volume: 68, Issue:7
Bioactive constituents of the leaves of Phyllanthus polyphyllus var. siamensis.
AID1335275Cytotoxicity against African green monkey BGM cells assessed as decrease in cell viability after 48 hrs by MTT assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Highly potent anti-leishmanial derivatives of hederagenin, a triperpenoid from Sapindus saponaria L.
AID1493996Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Cytotoxicity, Hemolytic Toxicity, and Mechanism of Action of Pulsatilla Saponin D and Its Synthetic Derivatives.
AID772917Cytotoxicity against human HL60 cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
Bioactive oleanane-type saponins from the rhizomes of Anemone taipaiensis.
AID1503736Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID1503730Antiproliferative activity against human MKN45 cells assessed as cell viability at 10 uM after 72 hrs by MTT assay relative to control2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID1442278Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay2017European journal of medicinal chemistry, Mar-31, Volume: 129The derivatives of Pulsatilla saponin A, a bioactive compound from Pulsatilla chinensis: Their synthesis, cytotoxicity, haemolytic toxicity and mechanism of action.
AID1503269Cytotoxicity in dog DH82 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
AID1617777Inhibition of human recombinant N-terminal His-tagged 15-LOX2 expressed in Escherichia coli assessed as residual activity at 42 uM using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1335271Antiparasitic activity against Leishmania infantum MHOM/BR/70/BH46 promastigotes infected in dog DH82 cells after 48 hrs by ELISA method2016European journal of medicinal chemistry, Nov-29, Volume: 124Highly potent anti-leishmanial derivatives of hederagenin, a triperpenoid from Sapindus saponaria L.
AID1617776Inhibition of human recombinant N-terminal His-tagged 15-LOX2 expressed in Escherichia coli using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by ferric ion oxidation-xylenol orange as2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1761200Reversal of P-glycoprotein mediated multidrug resistance in human KBV cells assessed as potentiation of paclitaxel-induced cytotoxicity by measuring cell survival rate at 10 uM measured after 72 hrs by MTT assay2021European journal of medicinal chemistry, Feb-05, Volume: 211Design, synthesis, and biological evaluation of hederagenin derivatives with improved aqueous solubility and tumor resistance reversal activity.
AID1442276Cytotoxicity against human KB cells assessed as reduction in cell viability after 48 hrs by MTT assay2017European journal of medicinal chemistry, Mar-31, Volume: 129The derivatives of Pulsatilla saponin A, a bioactive compound from Pulsatilla chinensis: Their synthesis, cytotoxicity, haemolytic toxicity and mechanism of action.
AID626970Inhibition of TNF-alpha-induced NFkappaB activation in human HepG2 cells after 1 hr by luciferase reporter assay2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Anti-inflammatory triterpenoid saponins from the stem bark of Kalopanax pictus.
AID1335270Antiparasitic activity against Leishmania infantum MHOM/BR/70/BH46 promastigotes infected in dog DH82 cells at 1000 uM after 48 hrs by ELISA method2016European journal of medicinal chemistry, Nov-29, Volume: 124Highly potent anti-leishmanial derivatives of hederagenin, a triperpenoid from Sapindus saponaria L.
AID393218Toxicity in sheep erythrocytes assessed as induction of hemolysis2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins.
AID1503747Cell cycle arrest in human MKN45 cells assessed as accumulation at S-phase at 10 uM after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 15%)2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID1503741Cell cycle arrest in human MKN45 cells assessed as apoptotic cell accumulation at 10 uM after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 1.51%)2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID1442274Hemolytic activity against New Zealand rabbit erythrocytes after 60 mins2017European journal of medicinal chemistry, Mar-31, Volume: 129The derivatives of Pulsatilla saponin A, a bioactive compound from Pulsatilla chinensis: Their synthesis, cytotoxicity, haemolytic toxicity and mechanism of action.
AID1256526Cytotoxicity against human MCF7 cells assessed as cell survival after 96 hrs by sulforhodamine B assay2015European journal of medicinal chemistry, Nov-13, Volume: 105Hederagenin as a triterpene template for the development of new antitumor compounds.
AID627013Inhibition of NF-kappaB-induced COX2 mRNA expression in TNF-alpha-stimulated human HepG2 cells at 0.1 to 10 uM after 1 hr by RT-PCR analysis2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Anti-inflammatory triterpenoid saponins from the stem bark of Kalopanax pictus.
AID977603pIC50 values for sodium fluorescein (10 uM) uptake in OATP1B3-transfected CHO cells2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1503261Cytotoxicity against human A2780 cells assessed as reduction in cell viability incubated fro 96 hrs by SRB assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
AID772916Cytotoxicity against human A549 cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
Bioactive oleanane-type saponins from the rhizomes of Anemone taipaiensis.
AID1617468Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M/C797S mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo ki2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID1335276Selectivity index, ratio of LD50 for human HepG2 cells to IC50 for Leishmania infantum MHOM/BR/70/BH46 promastigotes infected in dog DH82 cells2016European journal of medicinal chemistry, Nov-29, Volume: 124Highly potent anti-leishmanial derivatives of hederagenin, a triperpenoid from Sapindus saponaria L.
AID1256527Cytotoxicity against human A549 cells assessed as cell survival after 96 hrs by sulforhodamine B assay2015European journal of medicinal chemistry, Nov-13, Volume: 105Hederagenin as a triterpene template for the development of new antitumor compounds.
AID1728066Activation of AMPK in human Huh-7 cells assessed as increase in AMPK phosphorylation at Thr172 residue at 10 uM measured after 12 hrs by Western blot analysis2021European journal of medicinal chemistry, Jan-01, Volume: 209Synthesis and anti-inflammatory activity of saponin derivatives of δ-oleanolic acid.
AID1493992Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Cytotoxicity, Hemolytic Toxicity, and Mechanism of Action of Pulsatilla Saponin D and Its Synthetic Derivatives.
AID1503253Antiparasitic activity against Leishmania infantum2017European journal of medicinal chemistry, Nov-10, Volume: 140Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
AID1503277Cytotoxicity in human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
AID1503735Antiproliferative activity against human KBV cells after 72 hrs by MTT assay2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID1292208Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay2016European journal of medicinal chemistry, Jun-10, Volume: 115Novel hederagenin-triazolyl derivatives as potential anti-cancer agents.
AID772914Cytotoxicity against human HeLa cells assessed as cell viability after 72 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
Bioactive oleanane-type saponins from the rhizomes of Anemone taipaiensis.
AID1292211Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay2016European journal of medicinal chemistry, Jun-10, Volume: 115Novel hederagenin-triazolyl derivatives as potential anti-cancer agents.
AID1617778Inhibition of ovine recombinant COX1 assessed as decrease in formation of PGE2 using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID750462Antiviral activity against pseudo HCV infected in human 293T cells assessed as inhibition of HCV pseudo particles entry at 10 uM after 72 hrs by luciferase reporter gene assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Development of oleanane-type triterpenes as a new class of HCV entry inhibitors.
AID1503276Selectivity index, ratio of CC50 for African green monkey BGM cells to IC50 for antileishmanial activity against Leishmania infantum MHOM/BR/70/BH46 intracellular amastigotes infected in canine DH82 cells2017European journal of medicinal chemistry, Nov-10, Volume: 140Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
AID393221Cytotoxicity against human WS1 cells after 48 hrs by resazurin reduction test2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins.
AID1503732Antiproliferative activity against human KB cells assessed as cell viability at 10 uM after 72 hrs by MTT assay relative to control2017European journal of medicinal chemistry, Dec-01, Volume: 141Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
AID1256524Cytotoxicity against human A2780 cells assessed as cell survival after 96 hrs by sulforhodamine B assay2015European journal of medicinal chemistry, Nov-13, Volume: 105Hederagenin as a triterpene template for the development of new antitumor compounds.
AID1292210Cytotoxicity against human A549 cells after 96 hrs by SRB assay2016European journal of medicinal chemistry, Jun-10, Volume: 115Novel hederagenin-triazolyl derivatives as potential anti-cancer agents.
AID402640Cytotoxicity against human NCI-H187 cells by colorimetric method2005Journal of natural products, Jul, Volume: 68, Issue:7
Bioactive constituents of the leaves of Phyllanthus polyphyllus var. siamensis.
AID1543902Cytotoxicity against human A2780 cells assessed as reduction in cell viability after 96 hrs by SRB assay2019European journal of medicinal chemistry, Apr-15, Volume: 168Hederagenin amide derivatives as potential antiproliferative agents.
AID1617463Antiproliferative activity against human KB-VIN10 cells incubated for 72 hrs by SRB assay2019Journal of natural products, 11-22, Volume: 82, Issue:11
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
AID1292213Cytotoxicity against human 8505C cells after 96 hrs by SRB assay2016European journal of medicinal chemistry, Jun-10, Volume: 115Novel hederagenin-triazolyl derivatives as potential anti-cancer agents.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (128)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (3.13)18.7374
1990's8 (6.25)18.2507
2000's22 (17.19)29.6817
2010's67 (52.34)24.3611
2020's27 (21.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (3.05%)6.00%
Case Studies1 (0.76%)4.05%
Observational1 (0.76%)0.25%
Other125 (95.42%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research Highlights

Safety/Toxicity (6)

ArticleYear
Hederagenin potentiated cisplatin- and paclitaxel-mediated cytotoxicity by impairing autophagy in lung cancer cells.
Cell death & disease, 08-13, Volume: 11, Issue: 8
2020
Cytotoxicity, Hemolytic Toxicity, and Mechanism of Action of Pulsatilla Saponin D and Its Synthetic Derivatives.
Journal of natural products, 03-23, Volume: 81, Issue: 3
2018
The derivatives of Pulsatilla saponin A, a bioactive compound from Pulsatilla chinensis: Their synthesis, cytotoxicity, haemolytic toxicity and mechanism of action.
European journal of medicinal chemistry, Mar-31, Volume: 129
2017
Akebia saponin D, a saponin component from Dipsacus asper Wall, protects PC 12 cells against amyloid-beta induced cytotoxicity.
Cell biology international, Volume: 33, Issue: 10
2009
Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins.
Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue: 5
2009
Structure-activity relationships of some hederagenin diglycosides: haemolysis, cytotoxicity and apoptosis induction.
Biochimica et biophysica acta, Volume: 1760, Issue: 9
2006
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Long-term Use (1)

ArticleYear
Involvement of norepinephrine and serotonin system in antidepressant-like effects of hederagenin in the rat model of unpredictable chronic mild stress-induced depression.
Pharmaceutical biology, Volume: 53, Issue: 3
2015
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pharmacokinetics (2)

ArticleYear
Pharmacokinetics study of asperosaponin VI and its metabolites cauloside A, HN saponin F and hederagenin.
Journal of natural medicines, Volume: 68, Issue: 3
2014
Simultaneous determination of asperosaponin VI and its active metabolite hederagenin in rat plasma by liquid chromatography-tandem mass spectrometry with positive/negative ion-switching electrospray ionization and its application in pharmacokinetic study.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, Nov-15, Volume: 879, Issue: 30
2011
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (1)

ArticleYear
Synthesis and anti-inflammatory activity of saponin derivatives of δ-oleanolic acid.
European journal of medicinal chemistry, Jan-01, Volume: 209
2021
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (1)

ArticleYear
Inhibitory effects of diterpene acids from root of Aralia cordata on IgE-mediated asthma in guinea pigs.
Pulmonary pharmacology & therapeutics, Volume: 23, Issue: 3
2010
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]